Ledipasvir CAS: 1256388-51-8 (GS 588)

China Ledipasvir CAS: 1256388-51-8 (GS 588), Find details about China 1256388-51-8, Ledipasvir from Ledipasvir CAS: 1256388-51-8 (GS 588)

Model NO.
Royal pharm
Trademark
ROYAL PHARM
Transport Package
as Customers Requirement
Specification
99%
Origin
China
HS Code
2941909000
Model NO.
Royal pharm
Trademark
ROYAL PHARM
Transport Package
as Customers Requirement
Specification
99%
Origin
China
HS Code
2941909000
Ledipasvir
 
Our factory capacity: 5kg/month
Product name: Ledipasvir
CAS: 1256388-51-8
Other name: GS 588

Application:
  Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C, it is an inhibitor of the hepatitis C virus NS5A protein. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.
Package: 1kg/aluminum bag
 
 The following intermediates are available:
1256387-87-7 ,1441673-92-2, 74761-42-5, 1441670-89-8 ,  1499193-60-6
   P.S. The products above are only for R&D purposes. 

Specification Sheet (COA):
ItemsSpecificationsTest ResultsMethod
AppearanceOff-white to light brown powderLight yellow powderVisual
IdentificationThe retention time correspond to reference standardConformHPLC
The IR spectrum correspond to reference standardConformIR
Specific rotation-180.0°~-160.0°-169.5°USP<781>
Loss on dryingNMT 0.5%0.12%USP<731>
Residue on ignitionNMT 0.2%0.07%USP<281>
Heavy metalNMT 20ppmConformUSP<231>
Related substanceMaximum individual impurity
: NMT 0.1%
0.07%HPLC
Total impurities: NMT 1.0%0.30%HPLC
PurityNLT 99.5%99.7%HPLC